← Leaderboards
Jiapeng Huang
University Of Louisville
$1,551,210
Attributed
$4,653,631
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,653,631 · 2
By mechanism
R01$4,653,631 · 2
Top collaborators
- Silvia M Uriarte7 shared
- Jun Yan7 shared
Most similar at University Of Louisville
Same institution · by research overlap
- Silvia M Uriarte$8,211,635
- Jun Yan$16,605,525
- Dahai Luo$228,307
- Kenneth R McLeish$810,652
Others in their field
Other Rising Stars on “Exocytosis”
- Nagendran Ramalingam · Brigham And Women'S Hospital$2,996,571
- Fouad T Chebib · Mayo Clinic Jacksonville$2,967,657
- Sathish K Ramakrishnan · Yale University$2,313,209
- Matthew Ng Poy · Johns Hopkins University$1,217,971
- Zheng Shi · Rutgers, The State Univ Of N.J.$1,208,135
- Leyla Esfandiari · University Of Cincinnati$1,203,514
Research focus
ExocytosisFibrin Fragment DDisease ProgressionEconomicsFcgr3b GeneExtracellularCytokine Release SyndromeDensityCovid-19Covid-19/ArdsCytokineAcute Lung InjuryAntimicrobialBlood Coagulation DisordersAcute Respiratory Distress SyndromeCovid-19 PatientBronchoalveolar Lavage FluidCytoplasmic GranulesCells2019-NcovChemotaxisBilateralAntibodiesFunctional Disorder
Grant awards (7)
Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19$720,048
R01 · FY2025 · HL
Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS$556,881
R01 · FY2025 · AI
Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19$705,648
R01 · FY2024 · HL
Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS$574,104
R01 · FY2024 · AI
Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19$761,423
R01 · FY2023 · HL
Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS$574,104
R01 · FY2023 · AI
Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19$761,423
R01 · FY2022 · HL